## Abstract ## BACKGROUND. The aim was to determine the long‐term outcome for patients with FIGO stage IV epithelial ovarian carcinoma (EOC) treated with intraperitoneal (IP) chemotherapy after second‐look assessment. ## METHODS. By using data from a retrospective cohort of 433 patients who rece
Long-term follow-up results of fertility sparing surgery in patients with epithelial ovarian cancer
✍ Scribed by Juan P. Anchezar; Juan Sardi; Alejandro Soderini
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 73 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background and Objective
To assess clinical and obstetric outcome in young patients with epithelial ovarian cancer treated with fertility sparing surgery.
Methods
Eighteen patients younger than 40 years carrying epithelial ovarian tumors were submitted to fertility sparing surgery between 1988 and 2003. Disease‐free (DFS) and overall survival (OS) were analyzed using the Kaplan–Meier method. Statistical analysis was performed with the χ^2^ test.
Results
Disease free survival (DFS) 83.3% and overall survival (OS) 94.4% of patients treated with conservative surgery at 10 years. Up to date, six of seven patients who attempted pregnancy delivered seven healthy newborns.
Conclusion
Conservative surgery in young women with epithelial ovarian cancer is an appropriate therapeutic option in patients who wish to preserve childbearing potential. Long‐term follow‐up results shows excellent overall survival and pregnancy results. J. Surg. Oncol. 2009;100:55–58. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Patients with aggressive non‐Hodgkin lymphoma (NHL) require intensive and extensive therapy, which seems impracticable in elderly patients due to hematologic and extrahematologic toxicity. Consequent dose reduction and therapy attenuation can reduce treatment‐related toxi
## Objective To compare the effectiveness of amisulpride in acute (up to 8 weeks) and maintenance (week 8 to 12 months) phases of a 12‐month course of treatment in a heterogeneous group of patients with schizophrenia. ## Methods We conducted a 12‐month, open‐label clinical trial with flexible dos
## Background: Neoadjuvant chemotherapy has been reported to be extremely active in head and neck cancer but has failed to give a statistically significant improvement in survival. ## Methods: From 1981 to 1994, 33 operable patients with locally advanced oral cavity cancer received cisplatin-base